All Articles

A nearly $1 billion investment in HR Path isn't just about corporate growth; it's a high-stakes bet on fundamentally rewiring global employment for the digital age.

A private equity firm’s majority investment in services provider Smartlink reveals the real story: the gold rush is in the picks and shovels powering the digital world.

With Natalie Hagstrom at the helm, the wellness brand signals a strategic pivot. We decode what this CPG-heavy leadership means for its future growth.

Children's apparel giant Carter's isn't just cleaning up its supply chain; it's building a strategic moat of consumer trust and long-term brand value.

After 25 years, the influential Lucie and André Chagnon Foundation appoints its first independent Chair, a move signaling a major evolution in strategy.

At a UN forum in Geneva, a non-profit is urging global leaders to adopt blockchain as the essential foundation for trust and accountability in AI systems.

How the Danish liquorice maker leveraged a private equity buyout and a cult-like fan base to deliver 19% growth amid a global cocoa crisis.

Keenova Therapeutics' positive Phase 3 results for XIAFLEX could bring the first-ever approved drug for plantar fibromatosis, a painful, disabling condition.

Calumet's $100M debt redemption is more than a fiscal cleanup; it's a calculated move to fuel innovation in renewable fuels and specialty chemicals.

Evogene and Tel Aviv University are pairing generative AI with lab validation to bridge the 'valley of death' for academic drug research in Israel.

Beyond record gold output, K92 Mining’s Q2 results reveal a strategic blueprint for growth, engineering prowess, and navigating geopolitical complexity.

Shoppers Drug Mart's new obesity program isn't just about weight loss; it's a strategic leap into primary care, challenging how we access healthcare.

A new partnership between STARCARES and B-LEAD 2026 is more than charity; it's a strategic move to cultivate talent and redefine corporate impact in Vietnam.

Preclinical data shows GLIX1 can make PARP inhibitors effective in previously unresponsive tumors, a potential game-changer for 50% of ovarian cancer patients.

Bio-Techne's new AI-designed proteins tackle a critical hurdle in regenerative medicine: scalable manufacturing. This is how digital tools are industrializing biology.

IDfy's win in a key government challenge is more than a trophy. It's a signal that for Indian businesses, data privacy is no longer a checklist, but core infrastructure.

A crypto-backed nonprofit is pitching blockchain to UN diplomats as the essential trust layer for AI, signaling a strategic shift from speculation to governance.

With $2M in funding, Halifax-based Floqer is already cashflow positive by solving the true bottleneck in business today: customer understanding.

With the UAE's mandatory e-invoicing deadline approaching, Azentio Software has launched an AI-powered solution with pre-approved government status to ease compliance.

A new hospital network in Bangalore is giving clinicians equity, betting that ownership can restore trust and improve care. It's a bold test for a new model.